Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes: Phase 3b Multi-center Trial for Model Development
Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes: Phase 3b Multi-center Trial for Model Development
The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hydration status, including: 1) at various timepoints throughout a 24-hour period in healthy adults from the general population (GENPOP), and 2) before and after a team coach-led training session in athletes competing in a sport (ATHLETE). TOI data will be collected alongside standard reference measures of hydration status.
In this study each subject will serve as their own control.
Inclusion Criteria:
Both Study Arms (GENPOP and ATHLETE)
GENPOP Study
ATHLETE Study
Exclusion Criteria:
Both Study Arms (GENPOP and ATHLETE)
GENPOP Study
• Subject has a health condition or is taking medication that can be worsened by fluid restriction (participants who opt-in to fluid restriction study arm only)
Matt.Hinkley@pepsico.com914-742-4975
Bradenton, Florida 34210, United States
khalil.Lee@pepsico.com334-728-0250
Matt.Hinkley@pepsico.com914-742-4975
Shellen.Goltz@pepsico.com312-821-3317
Matt.Hinkley@pepsico.com914-742-4975
Matt.Hinkley@pepsico.com914-742-4975
Anthony.Wolfe@pepsico.com469-920-2862
Matt.Hinkley@pepsico.com914-742-4975